Literature DB >> 12932462

Susceptibility corrections in solid-state NMR experiments with oriented membrane samples. Part I: applications.

Ralf W Glaser1, Anne S Ulrich.   

Abstract

Chemical shift referencing of solid-state NMR experiments on oriented membranes has to compensate for bulk magnetic susceptibility effects that are associated with the non-spherical sample shape, as described in the accompanying paper [J. Magn. Reson. 164 (2003) 115-127]. The resulting frequency deviations can be on the order of 10 ppm, which is serious for nuclei with a narrow chemical shift anisotropy such as 1H or 13C, and in some cases even 19F. Two referencing schemes are proposed here to compensate for these effects: A flat (0.4 mm) glass container with an isotropic reference molecule dissolved in a thin film of liquid is stacked on top of the oriented membrane sample. Alternatively, the intrinsic proton signal of the hydrated lipid can be used for chemical shift referencing. Further aspects related to magnetic susceptibility are discussed, such as air gaps in susceptibility-matched probeheads, the benefits of shimming, and limitations in the accuracy of orientational constraints. A biological application is illustrated by a series of experiments on the antimicrobial peptide PGLa, aimed at understanding its concentration-dependent membranolytic effect. To address a wide range of molar peptide/lipid ratios between 1:3000 and 1:8, multilayers of hydrated DMPC containing a 19F-labeled peptide were oriented between stacked glass plates. Maintaining an approximately constant amount of peptide gives rise to thick samples (18 plates) at low, and thin samples (3 plates) at high peptide/lipid ratio. Accurate referencing was critical to reveal a small but significant change over 5 ppm in the anisotropic chemical shift of the 19F label on the peptide, indicative of a change in the orientation and/or dynamics of PGLa in the membrane.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12932462     DOI: 10.1016/s1090-7807(03)00207-6

Source DB:  PubMed          Journal:  J Magn Reson        ISSN: 1090-7807            Impact factor:   2.229


  6 in total

1.  Concentration-dependent realignment of the antimicrobial peptide PGLa in lipid membranes observed by solid-state 19F-NMR.

Authors:  Ralf W Glaser; Carsten Sachse; Ulrich H N Dürr; Parvesh Wadhwani; Sergii Afonin; Erik Strandberg; Anne S Ulrich
Journal:  Biophys J       Date:  2005-02-04       Impact factor: 4.033

2.  Solid-state NMR analysis of the PGLa peptide orientation in DMPC bilayers: structural fidelity of 2H-labels versus high sensitivity of 19F-NMR.

Authors:  Erik Strandberg; Parvesh Wadhwani; Pierre Tremouilhac; Ulrich H N Dürr; Anne S Ulrich
Journal:  Biophys J       Date:  2005-12-09       Impact factor: 4.033

3.  Homo- and heteromeric interaction strengths of the synergistic antimicrobial peptides PGLa and magainin 2 in membranes.

Authors:  Jonathan Zerweck; Erik Strandberg; Jochen Bürck; Johannes Reichert; Parvesh Wadhwani; Olga Kukharenko; Anne S Ulrich
Journal:  Eur Biophys J       Date:  2016-04-06       Impact factor: 1.733

4.  Action of the multifunctional peptide BP100 on native biomembranes examined by solid-state NMR.

Authors:  Julia Misiewicz; Sergii Afonin; Stephan L Grage; Jonas van den Berg; Erik Strandberg; Parvesh Wadhwani; Anne S Ulrich
Journal:  J Biomol NMR       Date:  2015-01-24       Impact factor: 2.835

5.  In situ NMR spectroscopy of supercapacitors: insight into the charge storage mechanism.

Authors:  Hao Wang; Alexander C Forse; John M Griffin; Nicole M Trease; Lorie Trognko; Pierre-Louis Taberna; Patrice Simon; Clare P Grey
Journal:  J Am Chem Soc       Date:  2013-12-04       Impact factor: 15.419

6.  Structure analysis and conformational transitions of the cell penetrating peptide transportan 10 in the membrane-bound state.

Authors:  Susanne Fanghänel; Parvesh Wadhwani; Erik Strandberg; Wouter P R Verdurmen; Jochen Bürck; Sebastian Ehni; Pavel K Mykhailiuk; Sergii Afonin; Dagmar Gerthsen; Igor V Komarov; Roland Brock; Anne S Ulrich
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.